Upregulation of TGFBR2 enables pro-apoptotic activity of TGF-β1 and inhibits the growth of prostate cancer cells through a caspase-1-mediated mechanism, whereas downregulation of this receptor leads to stimulation of malignant transformation [235,236]. This evidence concerns the gene TGFB1 and prostate cancer.